These data suggest the induction of FABP4 mRNA, and de novo FABP4 protein synthesis (in response to cellular steatosis) may act as a compensatory mechanism to account for a lack in increased FABP1, but does not account for elevated FABP4 in the cell culture medium. The gene discussed is FABP1; the disease is steatosis.